Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099749 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
A Phase 2 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 255
- Enrollment target
NCT00099749 is a Phase 2 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 255 participants.
The verdict
NCT00099749, a Phase 2 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 255 participants
- Enrollment target
Study Summary
The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.
Interventions
- DRUG FTY 720
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2003-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00099749
The ClinicalTrials.gov registry entry for NCT00099749 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FTY 720 is the first listed.
NCT00099749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00099749 about?
NCT00099749 is a clinical study titled "Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant". The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.
What is the current status of trial NCT00099749?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 255 participants. The study started on 2003-11.
What interventions are being tested in trial NCT00099749?
The interventions under investigation include: FTY 720 (DRUG).
Who is sponsoring clinical trial NCT00099749?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.